What question did this study set out to answer?

Assess the therapeutic role, efficacy, and treatment protocols of corticosteroids in managing myocarditis induced by immune checkpoint inhibitor cancer therapies.

August 6, 2024JACC CardioOncologyOpen Access

Steroids in Immune Checkpoint Inhibitor Myocarditis

View Full Paper

Ask AI

Bookmark

Authors

NPNicolas L. PalaskasThe University of Texas MD Anderson Cancer Center BSBilal A. SiddiquiThe University of Texas MD Anderson Cancer Center ADAnita DeswalCross-Cutting Cardiology

Discussion

Member takes

Implication

Clinical review reveals therapeutic responses to corticosteroids in patients with immune checkpoint inhibitor myocarditis, highlighting the need for prompt immunosuppression.

Key Points

Assess the therapeutic role, efficacy, and treatment protocols of corticosteroids in managing myocarditis induced by immune checkpoint inhibitor cancer therapies.
Synthesizes clinical evidence and management strategies for immune checkpoint inhibitor-related myocarditis.
Establishes high-dose corticosteroids as the primary first-line immunosuppressive intervention to mitigate acute immune-mediated cardiac inflammation.
Notes inconsistent response rates to steroid monotherapy, emphasizing the need for timely initiation and escalation to alternative immunosuppressants in refractory cases.

Cite This Study

Palaskas et al. (2024) studied this question.

synapsesocial.com/papers/6a925c5a454b8748a3f0ca9c https://doi.org/10.1016/j.jaccao.2024.07.002

View Full Paper

Ask AI

Bookmark

Implication

Clinical review reveals therapeutic responses to corticosteroids in patients with immune checkpoint inhibitor myocarditis, highlighting the need for prompt immunosuppression.

Steroids in Immune Checkpoint Inhibitor Myocarditis

Discussion

Member takes

Implication

Key Points

Cite This Study

Steroids in Immune Checkpoint Inhibitor Myocarditis

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider